Influence of Different Parameters on Extubation Time After Cardiac Surgery.
NCT ID: NCT03309280
Last Updated: 2020-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
132 participants
OBSERVATIONAL
2017-10-09
2018-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Delta Pulse Pressure and Delta Down Before and After Sternotomy
NCT03047850
Effect of Dobutamine on Hepatic Blood Flow During Goal-directed Hemodynamic Therapy
NCT04893655
Perioperative Cardiac Troponin Levels in Healthy Adults
NCT02394288
Norepinephrine in the Management of General Anesthesia-Induced Arterial Hypotension in Chronic Heart Failure Patients
NCT06350929
Development and Validation of Models to Predict Postoperative Complications for Patients With Cardiac Surgery
NCT04884841
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient at risk for OSA scheduled for Cardiac surgery
Patients with a positive STOP-Bang and DES-OSA score (that means patients at risk for OSA)
Duration of intubation
Time between intubation in the operating room and exhumation in the Intensive Care Unit.
Evolution of the renal function
Evolution of the renal function in the next two days
Patient not at risk for OSA scheduled for Cardiac surgery
Patients with a negative STOP-Bang and DES-OSA score (that means patients not at risk for OSA)
Duration of intubation
Time between intubation in the operating room and exhumation in the Intensive Care Unit.
Evolution of the renal function
Evolution of the renal function in the next two days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Duration of intubation
Time between intubation in the operating room and exhumation in the Intensive Care Unit.
Evolution of the renal function
Evolution of the renal function in the next two days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Astes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eric DEFLANDRE, MD, PhD, FCCP, FAHA
Head of Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric Deflandre
Role: PRINCIPAL_INVESTIGATOR
Astes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinique Saint-Luc de Bouge
Bouge, Namur, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VACC Study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.